| Date | Title | Description |
| 14.07.2026 | Body Fluid Analysis Market to Reach $3.65 Billion by 2031 | The global body fluid analysis market is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031, at a CAGR of 6.9% during the forecast period. Market growth is primarily driven by the increasing global incidence of infe... |
| 13.07.2026 | Molecular Cytogenetics Market to Reach $1.43 Billion by 2030 | The global molecular cytogenetics market is projected to grow from USD 1.02 billion in 2025 to USD 1.43 billion by 2030, at a CAGR of 7.1% during the forecast period. Market growth is primarily driven by the increasing incidence of cancer a... |
| 07.07.2026 | Molecular Diagnostics Market to Reach $30.74 Billion by 2030 | The global molecular diagnostics market is estimated at USD 19.48 billion in 2025 and is projected to reach USD 30.74 billion by 2030, growing at a CAGR of 9.6% during the forecast period. Market expansion is driven by increasing investment... |
| 06.07.2026 | Immunoassay Market to Reach $47.7 Billion by 2030 | The global Immunoassay market is projected to grow from USD 35.5 billion in 2025 to USD 47.7 billion by 2030, at a CAGR of 6.1% during the forecast period. Market growth is primarily driven by the expanding elderly population and the increa... |
| 02.04.2026 | Semarion Secures $3.8M to Propel Cell Assay Technology in Drug Discovery | Semarion, a pioneering Cambridge biotech firm, successfully raised $3.8 million. This strategic funding fuels the company's aggressive commercial expansion plans. It scales manufacturing of its groundbreaking SemaCyte platform. SemaCyte rev... |
| 01.04.2026 | Semarion: University of Cambridge Spin-Out Raises $3.8 Million To Scale Cell Assay Technology For Drug Discovery | Semarion, a University of Cambridge spin-out focused on advancing cell-based research, announced it has raised $3.8 million to expand its next-generation cell assay technology and accelerate adoption across the pharmaceutical industry. The ... |
| 01.04.2026 | Semarion Raises $3.8M in Funding | Semarion, a Cambridge, UK-based a biotechnology company which specializes in drug screening solutions, raised $3.8M in funding.
The round was led by Parkwalk, with participation from the FSE Group, Cambridge Enterprise Ventures, Oxford Inno... |
| 20.02.2026 | Accelerating India’s R&D Revolution: How 2025 Made Integration and Collaboration the New Standards | Revvity Signals | Share
Share
Share
Share
Email
2025 was a year defined by momentum, across science, data, and the rapidly evolving ecosystems that enable modern R&D. Organizations around the world continued to push for greater connectivity, smarter work... |
| 20.01.2026 | Soulmates Ventures Backs FluoSphera Rethinking Preclinical Drug Development | With Soulmates Ventures’ support, Fluosphera is building scalable, human-relevant preclinical models to reduce drug development failure Its multiplexed platform enables early, decision-grade insights across multiple interacting human tissue... |
| 15.01.2026 | Wall Street Braves Political Storm, Earnings Jitters, and Inflation Waves | Wall Street navigated intense volatility. A widening White House-Federal Reserve feud raised alarms over central bank independence. The Justice Department reportedly subpoenaed the Fed Chair. This action amplified fears of political interfe... |
| 13.01.2026 | FluoSphera Secures €1.23M to Revolutionize Drug Discovery with Human-Relevant Platform | FluoSphera, a Swiss biotech firm, secured €1.23 million. This vital funding propels its advanced drug discovery platform. The patented multi-tissue system offers animal-free, human-relevant testing. It predicts drug effects with high accura... |
| 13.01.2026 | Wall Street slips from its records as JPMorgan Chase and Delta kick off earnings season | Getting your Trinity Audio player ready...
By STAN CHOE, AP Business Writer
NEW YORK (AP) — Wall Street is slipping from its records on Tuesday following a mixed start to the latest profit reporting season for big U.S. companies. Related Ar... |
| 12.01.2026 | Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team | T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., ... |
| 12.01.2026 | FluoSphera Raises CHF 1.15M to Scale Human-Based Preclinical Platform |
Developing a new drug takes on average 10 to 15 years, and costs between $2 and $3 billion, according to Deloitte’s 2023 Pharmaceutical Innovation Report. Yet, despite these investments, over 90% of drug candidates still fail in clinical t... |
| 30.10.2025 | - | Tiger's November 12-13 auction will feature approximately $74 million in assets from Natron.
Among the brands up for auction are Hitachi, Itech, Frontier LLC and Xingtai Naknor.
"Tiger is pleased to have been selected to perform the li... |
| 27.09.2025 | Colorado Green Business Network announces 24k Gold Award and Innovation Spotlight Awards to honor businesses | Denver (September 26, 2025) – Today, the Colorado Green Business Network awarded Arapahoe Basin Ski Area with the 24-Karat Gold Award for its commitment to sustainability and the success of the resort’s comprehensive waste reduction program... |
| 28.07.2025 | Stocks making the biggest moves midday: Tesla, Nike, Revvity, Anheuser-Busch and more | - |
| 08.06.2025 | Missed Tempus AI rally? 2 tech healthcare stocks to buy now | Tempus AI (NASDAQ: TEM) has taken Wall Street by storm, ranking among the best-performing equities of 2025.
Notably, the precision medicine company, leveraging artificial intelligence (AI) to personalize patient treatments, has surged more ... |
| 28.04.2025 | Revvity beats quarterly estimates on steady demand for medical equipment | Revvity beats quarterly estimates on steady demand for medical equipment
By ReutersApril 28, 202511:32 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Prahlad Singh, president and CEO of Revvity... |
| 28.04.2025 | Morning Bid: The toll from Trump's tariffs | Morning Bid: The toll from Trump's tariffs
By Mike DolanApril 28, 202510:52 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
CommentaryBy Mike Dolan
A futures-options trader works on the floor at... |
| 03.04.2025 | Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits | Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN), announces an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences ... |
| 21.03.2025 | The Future of Food: How Epigenetics and AI Are Transforming Agriculture | The world of agriculture is on the brink of a revolution. Two powerful forces are emerging: epigenetics and artificial intelligence (AI). Together, they promise to reshape how we grow food, making it more resilient, efficient, and sustainab... |
| 19.03.2025 | AI is revolutionizing R&D and supply chains in the food industry, but work remains in order to unlock full potential, reveals new MIT Technology Review Insights report | CAMBRIDGE, Mass., March 19, 2025 /PRNewswire/ -- A new report by MIT Technology Review Insights seeks to understand how the food industry can use AI to help meet the increasing global demand for nutritious, affordable produce, ensure resili... |
| 25.09.2024 | Vanderbilt University School of Medicine Basic Sciences Adds Carterra's LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care | The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules
SALT ... |
| 31.07.2024 | Navigating the Cloud: A FinOps Approach to Cost Management | In the digital age, the cloud is a double-edged sword. It offers flexibility and innovation but can also lead to spiraling costs. As organizations rush to adopt cloud technologies, they often find themselves in a financial maze. The key to ... |
| 31.07.2024 | Navigating the Future: The Intersection of AI and Project Management | In the fast-paced world of business, change is the only constant. Organizations are in a race to adapt, innovate, and thrive. At the heart of this transformation lies Project Portfolio Management (PPM). As companies grapple with the complex... |
| 31.07.2024 | Navigating the Cloud Cost Labyrinth: A FinOps Approach for Modern Enterprises | In the digital age, cloud computing is the lifeblood of innovation. Yet, as organizations rush to embrace this technology, they often find themselves ensnared in a web of escalating costs. The promise of flexibility and scalability can quic... |
| 31.07.2024 | Navigating the Future: The Imperative Shift in Transportation and Logistics IT Strategies | The transportation and logistics industry stands at a crossroads. Rapid technological advancements and shifting market demands are reshaping the landscape. Companies must adapt or risk being left behind. The latest research from Info-Tech R... |
| 30.07.2024 | McLean & Company Reveals New Agenda Details for McLean Signature, the Highly Anticipated Annual Industry Conference for HR Professionals | Global HR research and advisory firm and conference host McLean & Company has recently shared the full McLean Signature 2024 conference agenda. Set for October 27-29 in Las Vegas with speakers from Revvity, the Atlanta Braves, the Lucas... |
| 25.07.2024 | Element Biosciences: A New Era in DNA Sequencing**
** | ** Element Biosciences is on a mission. The San Diego-based company is reshaping the landscape of DNA sequencing and multi-omics technology. With a recent infusion of over $277 million in Series D funding, Element is poised to democratize a... |
| 23.07.2024 | Element Biosciences: Over $277 Million In Series D Raised For Democratizing Access To Advanced Biological Tools | Element Biosciences, a developer of pioneering technologies to empower science, announced over $277 million in Series D funding to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for year... |
| 19.06.2024 | GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments | SEOUL, South Korea, June 19, 2024 /PRNewswire/ -- GenKOre, a pioneer in gene editing technology with its proprietary hypercompact CRISPR, known as TaRGET, is pleased to announce a strategic collaboration with Revvity's Gene Delivery franchi... |
| 18.06.2024 | GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments | SEOUL, South Korea, June 18, 2024 /PRNewswire/ -- GenKOre, a pioneer in gene editing technology with its proprietary hypercompact CRISPR, known as TaRGET, is pleased to announce a strategic collaboration with Revvity's Gene Delivery franchi... |
| 26.09.2023 | Revvity expands access to base editing technology with aim to accelerate discovery to cure | Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology
Access to the Pin-point system now bridges discovery, preclinical and clinical with the same technology platform
Reagent launch puts clinically... |
| 28.07.2023 | Revvity Signals Software and Scitara Expand Strategic Relationship to Accelerate Laboratory Digital Transformation | Expanded collaboration to help drive research productivity in labs with unique, iPaaS-based approach to data integration
Revvity Signals Software adds new laboratory integration offering to its portfolio with embedded Scitara Digital Lab Ex... |
| 12.06.2023 | Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development | Signals Research Suite integrates workflows across biology, chemistry and materials new product development to arm scientists with better data, insights and outcomes
Centrally installed and managed, the integrated suite covers the entire Ma... |
